SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LarryS who wrote (8137)12/28/1998 1:41:00 PM
From: Arthur Radley  Respond to of 17367
 
I don't know what it is but now volume up over 150,000 for daily average....but the stock just sits there.



To: LarryS who wrote (8137)12/28/1998 2:22:00 PM
From: Thomas J Pittman  Read Replies (1) | Respond to of 17367
 
I can confirm the 'mention'. There was a business
journalist talking about a pharmacia-upjohn drug in
phase 2 that was targeted at 'superbugs'. The host
specifically referred to sepis / staph infections.
Virtually all of the discussion was abou this drug
except for a split screen titled (something like)
'other companies with sepis drugs in late stages of
approval'. Xoma was listed there.

corrections appreciated.

J


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News